AIMedica is building the future of digital healthcare, where intelligent tools like MedMate become the first line of support for millions of people seeking trusted, immediate insight into their health.

We are currently in an active growth phase, targeting both private and public healthcare sectors with a scalable SaaS model and high-margin B2B contracts.

With a proven technical foundation, strong leadership team, and validated market need, AIMedica presents a rare opportunity to invest in a solution that combines real-world impact with measurable commercial potential.

If you’re looking to invest in a high-growth healthtech company with European expansion plans, regulatory clarity, and a clear roadmap to profitability, we invite you to connect with us. Let’s shape the next era of healthcare, together.